These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20878084)

  • 21. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes.
    Galamb O; Sipos F; Spisák S; Galamb B; Krenács T; Valcz G; Tulassay Z; Molnár B
    Cell Oncol; 2009; 31(1):19-29. PubMed ID: 19096147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
    Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y
    Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue and serum galectin-1 expression in patients with colorectal carcinoma.
    Sheng TH; Rong LX; Li ZY; Bo J; Lei S
    Hepatogastroenterology; 2012; 59(114):389-94. PubMed ID: 22353504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies.
    Oliveira Frick V; Rubie C; Ghadjar P; Faust SK; Wagner M; Gräber S; Schilling MK
    Tumour Biol; 2011 Feb; 32(1):189-96. PubMed ID: 20865359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence.
    Cui G; Yuan A; Goll R; Olsen T; Husebekk A; Vonen B; Florholmen J
    Cancer Immunol Immunother; 2007 Dec; 56(12):1993-2001. PubMed ID: 17579859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-surface markers for colon adenoma and adenocarcinoma.
    Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
    Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
    Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
    Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
    Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Analysis of microRNA Profiles in Organoids Derived from Human Colorectal Adenoma and Cancer.
    Nagai H; Kuroha M; Handa T; Karasawa H; Ohnuma S; Naito T; Moroi R; Kanazawa Y; Shiga H; Hamada S; Kakuta Y; Naitoh T; Kinouchi Y; Shimosegawa T; Masamune A
    Digestion; 2021; 102(6):860-869. PubMed ID: 33647915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
    Meng H; Li W; Boardman LA; Wang L
    BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer.
    Rubie C; Frick VO; Pfeil S; Wagner M; Kollmar O; Kopp B; Graber S; Rau BM; Schilling MK
    World J Gastroenterol; 2007 Oct; 13(37):4996-5002. PubMed ID: 17854143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
    Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysplasia-carcinoma transition specific transcripts in colonic biopsy samples.
    Galamb O; Wichmann B; Sipos F; Spisák S; Krenács T; Tóth K; Leiszter K; Kalmár A; Tulassay Z; Molnár B
    PLoS One; 2012; 7(11):e48547. PubMed ID: 23155391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KRAS mutation and abnormal expression of Cripto-1 as two potential candidate biomarkers for detection of colorectal cancer development.
    Igder S; Mohammadiasl J; Azadpour S; Mansouri E; Ashktorab H; Mokarram P
    J Cell Biochem; 2020 Apr; 121(4):2901-2908. PubMed ID: 31692030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.
    de Groen FL; Timmer LM; Menezes RX; Diosdado B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
    PLoS One; 2015; 10(7):e0132495. PubMed ID: 26148070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention.
    Guo X; Wang R; Chen R; Zhang Z; Wang J; Liu X
    Clin Chim Acta; 2024 Jun; 560():119732. PubMed ID: 38772522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic down-regulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence.
    Xu J; Lü B; Xu F; Gu H; Fang Y; Huang Q; Lai M
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):891-8. PubMed ID: 18264726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.